CELU Valuation

Celularity Inc

Add to Watchlist

Advanced Chart

3.930

+0.09(2.344%)1D

Overview
Forecast
Valuation
Earnings

CELU Relative Valuation

CELU's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CELU is overvalued; if below, it's undervalued.

Historical Valuation

Celularity Inc (CELU) is now in the Fair zone, suggesting that its current forward PS ratio of 1.43 is considered Fairly compared with the five-year average of -3.40. The fair price of Celularity Inc (CELU) is between 2.71 to 6.69 according to relative valuation methord.

Relative Value

Fair Zone

2.71-6.69

Current Price：3.93

Fair

-0.91

Trailing

Forward

-1.07

EV/EBITDA

Celularity Inc. (CELU) has a current EV/EBITDA of -1.07. The 5-year average EV/EBITDA is -2.22. The thresholds are as follows: Strongly Undervalued below -9.76, Undervalued between -9.76 and -5.99, Fairly Valued between 1.55 and -5.99, Overvalued between 1.55 and 5.32, and Strongly Overvalued above 5.32. The current Forward EV/EBITDA of -1.07 falls within the Historic Trend Line -Fairly Valued range.

-1.62

EV/EBIT

Celularity Inc. (CELU) has a current EV/EBIT of -1.62. The 5-year average EV/EBIT is -2.73. The thresholds are as follows: Strongly Undervalued below -8.86, Undervalued between -8.86 and -5.80, Fairly Valued between 0.34 and -5.80, Overvalued between 0.34 and 3.41, and Strongly Overvalued above 3.41. The current Forward EV/EBIT of -1.62 falls within the Historic Trend Line -Fairly Valued range.

1.43

Celularity Inc. (CELU) has a current PS of 1.43. The 5-year average PS is 20.61. The thresholds are as follows: Strongly Undervalued below -63.60, Undervalued between -63.60 and -21.50, Fairly Valued between 62.71 and -21.50, Overvalued between 62.71 and 104.81, and Strongly Overvalued above 104.81. The current Forward PS of 1.43 falls within the Historic Trend Line -Fairly Valued range.

-3.65

P/OCF

Celularity Inc. (CELU) has a current P/OCF of -3.65. The 5-year average P/OCF is -2.51. The thresholds are as follows: Strongly Undervalued below -8.92, Undervalued between -8.92 and -5.72, Fairly Valued between 0.69 and -5.72, Overvalued between 0.69 and 3.89, and Strongly Overvalued above 3.89. The current Forward P/OCF of -3.65 falls within the Historic Trend Line -Fairly Valued range.

-1.07

P/FCF

Celularity Inc. (CELU) has a current P/FCF of -1.07. The 5-year average P/FCF is -2.40. The thresholds are as follows: Strongly Undervalued below -9.46, Undervalued between -9.46 and -5.93, Fairly Valued between 1.13 and -5.93, Overvalued between 1.13 and 4.66, and Strongly Overvalued above 4.66. The current Forward P/FCF of -1.07 falls within the Historic Trend Line -Fairly Valued range.

Celularity Inc (CELU) has a current Price-to-Book (P/B) ratio of 9.80. Compared to its 3-year average P/B ratio of 2.11 , the current P/B ratio is approximately 363.94% higher. Relative to its 5-year average P/B ratio of 1.81, the current P/B ratio is about 440.56% higher. Celularity Inc (CELU) has a Forward Free Cash Flow (FCF) yield of approximately -7.01%. Compared to its 3-year average FCF yield of -72.15%, the current FCF yield is approximately -90.28% lower. Relative to its 5-year average FCF yield of -56.69% , the current FCF yield is about -87.63% lower.

9.80

P/B

Median3y

2.11

Median5y

1.81

-7.01

FCF Yield

Median3y

-72.15

Median5y

-56.69

Competitors Valuation Multiple

The average P/S ratio for CELU's competitors is 0.55, providing a benchmark for relative valuation. Celularity Inc Corp (CELU) exhibits a P/S ratio of 1.43, which is 160.34% above the industry average. Given its robust revenue growth of 49.70%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Research Solutions Inc

Performance Decomposition

Market capitalization of CELU increased by 27.60% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -0.54 to -1.45.

The secondary factor is the Revenue Growth, contributed 49.70%to the performance.

Overall, the performance of CELU in the past 1 year is driven by P/E Change. Which is more unsustainable.

49.70%

12.11M → 18.13M

Revenue Growth

-193.01%

78.82 → -73.31

Margin Expansion

170.91%

-0.54 → -1.45

P/E Change

27.60%